For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial

Type
D - Journal article
Title of journal
Lancet Oncol
Article number
-
Volume number
14
Issue number
-
First page of article
823
ISSN of journal
1474-5488
Year of publication
2013
Number of additional authors
9
Additional information

The author made a substantial contribution to the conception and design of the study, to the organisation of the conduct of the study and to carrying out the study (including acquisition of study data). The author made a contribution to the analysis and interpretation of study data and helped draft the output.

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
1
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-